Search

Author/Creator Di Carlo, D.

1. HBV reservoir and enhanced cccDNA transcriptional activity in HBeAg negative chronic hepatitis B. Issue 1 (February 2018)

Authors:
Colagrossi, L.; Salpini, R.; Gill, U.S.; Battisti, A.; Piermatteo, L.; Di Carlo, D.; Hansi, N.; Ceccherini-Silberstein, F.; Perno, C.F.; Kennedy, P.T.F.; Svicher, V.
Journal:
Digestive and liver disease
Issue:
Volume 50:Issue 1(2018)Supplement
Page Start:
27
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. HIV-1 integrase genotyping is reliable and reproducible for routine clinical detection of integrase resistance mutations even in patients with low-level viraemia. (23rd February 2015)

Authors:
Armenia, D.; Fabeni, L.; Alteri, C.; Di Pinto, D.; Di Carlo, D.; Bertoli, A.; Gori, C.; Carta, S.; Fedele, V.; Forbici, F.; D'Arrigo, R.; Svicher, V.; Berno, G.; Pizzi, D.; Nicastri, E.; Sarmati, L.; Pinnetti, C.; Ammassari, A.; D'Offizi, G.; Latini, A.
Journal:
Journal of antimicrobial chemotherapy
Issue:
Volume 70:Number 6(2015:Jun.)
Page Start:
1865
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Letter to the editor: switching treatment to lamivudine plus boosted atazanavir or darunavir in virologically suppressed HIV-infected patients – evidence from a large observational cohort. Issue 3 (4th March 2019)

Authors:
Bavaro, D. F.; Di Carlo, D.; Zuccalà, P.; Bai, F.; Incardona, F.; Battisti, A.; Giachè, S.; Salomoni, E.; Gagliardini, R.; Di Giambenedetto, S.; Pecorari, M.; Zazzi, M.; De Luca, A.; Bezenchek, A.; Lo Caputo, S.
Journal:
Infectious diseases
Issue:
Volume 51:Issue 3(2019)
Page Start:
234
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

8. Persistent risk of HBV reactivation despite extensive lamivudine prophylaxis in haematopoietic stem cell transplant recipients who are anti-HBc-positive or HBV-negative recipients with an anti-HBc-positive donor. (November 2016)

Authors:
Cerva, C.; Colagrossi, L.; Maffongelli, G.; Salpini, R.; Di Carlo, D.; Malagnino, V.; Battisti, A.; Ricciardi, A.; Pollicita, M.; Bianchi, A.; Picardi, A.; Cudillo, L.; Cerretti, R.; De Angelis, G.; Cantonetti, M.; Andreoni, M.; Perno, C.F.; Arcese, W.; Svicher, V.; Sarmati, L.
Journal:
Clinical microbiology and infection
Issue:
Volume 22:Number 11(2016)
Page Start:
946.e1
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

9. Pre-existent NRTI and NNRTI resistance impacts on maintenance of virological suppression in HIV-1-infected patients who switch to a tenofovir/emtricitabine/rilpivirine single-tablet regimen. (19th December 2016)

Authors:
Armenia, D.; Di Carlo, D.; Calcagno, A.; Vendemiati, G.; Forbici, F.; Bertoli, A.; Berno, G.; Carta, S.; Continenza, F.; Fedele, V.; Bellagamba, R.; Cicalini, S.; Ammassari, A.; Libertone, R.; Zaccarelli, M.; Ghisetti, V.; Andreoni, M.; Ceccherini-Silberstein, F.; Bonora, S.; Di Perri, G.
Journal:
Journal of antimicrobial chemotherapy
Issue:
Volume 72:Number 3(2017:Mar.)
Page Start:
855
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

10. Serum thymosin α 1 levels in patients with chronic inflammatory autoimmune diseases. (1st August 2016)

Authors:
Pica, F.; Chimenti, M. S.; Gaziano, R.; Buè, C.; Casalinuovo, I. A.; Triggianese, P.; Conigliaro, P.; Di Carlo, D.; Cordero, V.; Adorno, G.; Volpi, A.; Perricone, R.; Garaci, E.
Journal:
Clinical and experimental immunology
Issue:
Volume 186:Number 1(2016:Oct.)
Page Start:
39
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗